Novo Nordisk, the maker of Ozempic and Wegovy weight-loss drugs, just regained the title as Europe’s most valuable company ...

Find insight on Malaysia’s glove sector, Novo Nordisk and more in the latest Market Talks covering the Health Care sector.

The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an ...

Novo Nordisk’s shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe’s ...

NVDA Price Action: According to data from Benzinga Pro, Thursday’s strategic announcements are being cheered by investors. Shares of Nvidia closed Thursday afternoon at $145 a share, a gain of 1.52%.

While these new drugs are curbing enthusiasm for eating, they are also having a notable effect on food purchases.

The stock market is a place where people tend to panic when things go on sale. Instead, buy the dip on these four fabulous ...

(Reuters) -Indian contract drug manufacturer OneSource Specialty Pharma expects strong growth in its order book over the next three years, driven by the global boom in weight-loss drugs, its top ...

AstraZeneca’s share price has fallen a lot from its September high, but this could mean a tremendous opportunity for me to buy a great stock on the cheap. The post At a bargain-basement valuation now, ...

McDonald's faces a potential decline in sales due to the weight loss medications. Other fast-food chains like Domino's and KFC are also at risk, while Taco Bell and Chipotle are better positioned.

Novo Nordisk jumps 5% as Parvus Asset Management builds a stake to sway CEO succession amid leadership shakeup and pipeline ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.